Canada· CA-DIN-02470659

PERGOVERIS

A gonadotropine, kombinationen product containing lutropin alfa + follitropin alfa, registered in Canada by EMD SERONO, A DIVISION OF EMD INC., CANADA. The same ATC class is registered in 11 of our 19 countries.

ATC G03GA30

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedPERGOVERISATCG03GA30REGISTER NO.CA-DIN-02470659PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Gonadotropine, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC G03GA30 (gonadotropine, kombinationen), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose

Gonadotropine, kombinationen · ATC G03GA30

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
LUTROPIN ALFA + FOLLITROPIN ALFA
Manufacturer
EMD SERONO, A DIVISION OF EMD INC., CANADA
Country
Canada (CA)
ATC code
G03GA30
ATC class
Gonadotropine, Kombinationen
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Gonadotropine, kombinationen in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gonadotropine, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Pergoveris
  • Liechtenstein · Pergoveris
  • Norway · Pergoveris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad0cf11d-8fb9-4b39-8cc2-0c7da537aeda
GET /v1/drugs/ad0cf11d-8fb9-4b39-8cc2-0c7da537aeda?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02470659",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "SUBCUTANEOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "G03GA30",
  "schedule": [
    "Prescription",
    "Schedule D"
  ],
  "drug_code": "95966",
  "strengths": [
    "225 UNIT",
    "450 UNIT"
  ],
  "ahfs_class": null,
  "substances": [
    "LUTROPIN ALFA",
    "FOLLITROPIN ALFA"
  ],
  "product_categorization": null
}

See everything about gonadotropine, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.